These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7968645

  • 1. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism.
    Gambacciani M, Spinetti A, Cappagli B, Taponeco F, Maffei S, Piaggesi L, Fruzzetti F, Fioretti P.
    Maturitas; 1994 Aug; 19(2):125-31. PubMed ID: 7968645
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M, Cappagli B, Lazzarini V, Ciaponi M, Fruzzetti F, Genazzani AR.
    Maturitas; 2006 May 20; 54(2):176-80. PubMed ID: 16332417
    [Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics.
    Gambacciani M, Cappagli B, Ciaponi M, Benussi C, Genazzani AR.
    Menopause; 1999 May 20; 6(1):43-8. PubMed ID: 10100179
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
    Gambacciani M, Ciaponi M, Cappagli B, Benussi C, Genazzani AR.
    Osteoporos Int; 2000 May 20; 11(6):544-8. PubMed ID: 10982172
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
    Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Piaggesi L, Fioretti P.
    Obstet Gynecol; 1994 Mar 20; 83(3):392-6. PubMed ID: 8127531
    [Abstract] [Full Text] [Related]

  • 6. Biochemical aspects of hormonal contraception: effects on bone metabolism.
    Volpe A, Amram A, Cagnacci A, Battaglia C.
    Eur J Contracept Reprod Health Care; 1997 Jun 20; 2(2):123-6. PubMed ID: 9678101
    [Abstract] [Full Text] [Related]

  • 7. Very low estrogen-desogestrel contraceptive in perimenopausal hormonal replacement.
    Porcile A, Gallardo E, Onetto P, Schächter D.
    Maturitas; 1994 Feb 20; 18(2):93-103. PubMed ID: 8177098
    [Abstract] [Full Text] [Related]

  • 8. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL, Katz M.
    Contraception; 1979 Nov 20; 20(5):475-87. PubMed ID: 393456
    [Abstract] [Full Text] [Related]

  • 9. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
    Fioretti P, Fruzzetti F, Navalesi R, Ricci C, Miccoli R, Cerri M, Orlandi MC, Melis GB.
    Contraception; 1987 Mar 20; 35(3):229-43. PubMed ID: 2956055
    [Abstract] [Full Text] [Related]

  • 10. Bone loss in perimenopausal women: a longitudinal study.
    Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Maffei S, Manetti P, Piaggesi L, Fioretti P.
    Maturitas; 1994 Mar 20; 18(3):191-7. PubMed ID: 8015502
    [Abstract] [Full Text] [Related]

  • 11. Bone-sparing properties of oral contraceptives.
    DeCherney A.
    Am J Obstet Gynecol; 1996 Jan 20; 174(1 Pt 1):15-20. PubMed ID: 8571999
    [Abstract] [Full Text] [Related]

  • 12. Contraception in older woman.
    Volpe A, Silferi M, Genazzani AD, Genazzani AR.
    Contraception; 1993 Mar 20; 47(3):229-39. PubMed ID: 8462314
    [Abstract] [Full Text] [Related]

  • 13. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.
    Am J Obstet Gynecol; 1993 Nov 20; 169(5):1183-9. PubMed ID: 8238183
    [Abstract] [Full Text] [Related]

  • 14. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM, Fauser BC.
    Contraception; 1999 Apr 20; 59(4):237-43. PubMed ID: 10457868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
    Gargano V, Massaro M, Morra I, Formisano C, Di Carlo C, Nappi C.
    Contraception; 2008 Jul 20; 78(1):10-5. PubMed ID: 18555812
    [Abstract] [Full Text] [Related]

  • 17. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
    Naessen T, Olsson SE, Gudmundson J.
    Contraception; 1995 Jul 20; 52(1):35-9. PubMed ID: 8521712
    [Abstract] [Full Text] [Related]

  • 18. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
    Spona J, Elstein M, Feichtinger W, Sullivan H, Lüdicke F, Müller U, Düsterberg B.
    Contraception; 1996 Aug 20; 54(2):71-7. PubMed ID: 8842582
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F, Ricci C, Fioretti P.
    Contraception; 1994 Jun 20; 49(6):579-92. PubMed ID: 8070263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.